Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.

Cancer chemotherapy reports ·Vol. 54 ·No. 6 ·1970-12-00 ·Pages 431-50

Skipper HE, Schabel FM, Mellett LB, Montgomery JA, Wilkoff LJ, Lloyd HH, Brockman RW

Abstract

暂无摘要

MeSH Terms

Animals Antineoplastic Agents/administration & dosage,blood,toxicity Cyclophosphamide/administration & dosage Cytarabine/administration & dosage DNA, Neoplasm/biosynthesis Dactinomycin/administration & dosage Daunorubicin/administration & dosage Disease Models, Animal Fluorouracil/administration & dosage Half-Life Hydroxyurea/administration & dosage In Vitro Techniques Kinetics Leukemia L1210/drug therapy Mercaptopurine/administration & dosage Methotrexate/administration & dosage Mice Mitosis Nitrosourea Compounds/administration & dosage Thiosemicarbazones/administration & dosage

Chemicals

Antineoplastic Agents DNA, Neoplasm Nitrosourea Compounds Thiosemicarbazones Cytarabine Dactinomycin Cyclophosphamide Mercaptopurine Fluorouracil Hydroxyurea Methotrexate Daunorubicin

Authors & Affiliations

7 authors, click to expand affiliations / ORCID

Skipper H E

Schabel F M

Mellett L B

Montgomery J A

Wilkoff L J

Lloyd H H

Brockman R W

Article Info

Journal

Cancer chemotherapy reports

Abbr.

Cancer Chemother Rep

ISSN

0069-0112

Published

1970-12-00

Pages

431-50

Language

English

Region

United States

NLM ID

7607105

Subset

External Links

PubMed source

Analysis Services

Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.

Contact

WeChat Official Account